Publications en collaboration avec des chercheurs de King's College Hospital NHS Foundation Trust (2)

2019

  1. Correction to: Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE) (European Journal of Clinical Microbiology & Infectious Diseases, (2018), 37, 11, (2097-2106), 10.1007/s10096-018-3344-1)

    European Journal of Clinical Microbiology and Infectious Diseases

2018

  1. Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 37, Núm. 11, pp. 2097-2106